- Filed
- Jan 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 13, 2025 | 4.86M sh |
| Long Term Debt | Q1 2025 · Nov 30, 2024 | $4.18M |
| Long Term Debt | Q1 2025 · Aug 31, 2024 | $4.21M |
| Short Term Debt | Q1 2025 · Nov 30, 2024 | $131K |
| Short Term Debt | Q1 2025 · Aug 31, 2024 | $129K |
| Stockholders Equity | Q1 2025 · Nov 30, 2024 | $130.47M |
| Stockholders Equity | Q1 2025 · Aug 31, 2024 | $123.63M |
| Stockholders Equity | Q1 2025 · Nov 30, 2023 | $110.35M |
| Stockholders Equity | Q1 2025 · Aug 31, 2023 | $108.72M |
| Current Liabilities | Q1 2025 · Nov 30, 2024 | $59.69M |
| Current Liabilities | Q1 2025 · Aug 31, 2024 | $55.8M |
| Total Liabilities | Q1 2025 · Nov 30, 2024 | $68.3M |
| Total Liabilities | Q1 2025 · Aug 31, 2024 | $64.91M |
| Current Assets | Q1 2025 · Nov 30, 2024 | $153.03M |
| Current Assets | Q1 2025 · Aug 31, 2024 | $142M |
| Total Assets | Q1 2025 · Nov 30, 2024 | $198.76M |
| Total Assets | Q1 2025 · Aug 31, 2024 | $188.54M |
| Cash And Equivalents | Q1 2025 · Aug 31, 2024 | $843K |
| Shares Diluted restated | Q1 2025 · Nov 30, 2023 | 4.9M sh |
| Capex | Q1 2025 · Nov 30, 2023 | $31.7M |
| Operating Cash Flow | Q1 2025 · Nov 30, 2023 | $301K |
| Eps Diluted | Q1 2025 · Nov 30, 2023 | $0.36 |
| Eps Basic | Q1 2025 · Nov 30, 2023 | $0.36 |
| Sga Expense | Q1 2025 · Nov 30, 2023 | $17.22M |
| Net Income | Q1 2025 · Nov 30, 2023 | $1.78M |
| Operating Income | Q1 2025 · Nov 30, 2023 | $2.45M |
| Gross Profit | Q1 2025 · Nov 30, 2023 | $23.57M |
| Cost Of Revenue | Q1 2025 · Nov 30, 2023 | $56.68M |
| Revenue | Q1 2025 · Nov 30, 2023 | $80.26M |